DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,101,435 | -0.7% | 205,971 | -4.0% | 4.02% | +8.4% |
| Q2 2023 | $51,470,909 | +3.8% | 214,462 | +9.0% | 3.70% | -2.4% |
| Q1 2023 | $49,575,871 | -3.8% | 196,698 | +1.3% | 3.80% | -10.2% |
| Q4 2022 | $51,538,304 | +0.1% | 194,176 | -2.6% | 4.22% | -6.5% |
| Q3 2022 | $51,499,000 | -0.1% | 199,384 | -1.9% | 4.52% | +7.0% |
| Q2 2022 | $51,526,000 | -12.2% | 203,243 | +1.5% | 4.22% | +0.9% |
| Q1 2022 | $58,711,000 | -7.0% | 200,152 | +4.4% | 4.19% | -0.9% |
| Q4 2021 | $63,098,000 | +9.9% | 191,780 | +1.7% | 4.23% | -4.4% |
| Q3 2021 | $57,391,000 | +1.3% | 188,514 | -10.7% | 4.42% | +2.1% |
| Q2 2021 | $56,638,000 | +25.1% | 211,052 | +4.9% | 4.33% | +12.9% |
| Q1 2021 | $45,290,000 | +2.5% | 201,217 | +1.1% | 3.84% | -0.9% |
| Q4 2020 | $44,200,000 | -0.5% | 198,974 | -3.5% | 3.87% | -10.0% |
| Q3 2020 | $44,406,000 | +13.1% | 206,222 | -7.1% | 4.30% | +0.1% |
| Q2 2020 | $39,250,000 | +18.3% | 221,963 | -7.4% | 4.30% | +0.2% |
| Q1 2020 | $33,176,000 | -15.2% | 239,691 | -5.9% | 4.29% | +1.5% |
| Q4 2019 | $39,100,000 | +8.2% | 254,759 | +1.8% | 4.23% | -0.0% |
| Q3 2019 | $36,152,000 | +1.2% | 250,310 | +0.1% | 4.23% | -0.7% |
| Q2 2019 | $35,740,000 | +7.7% | 250,068 | -0.5% | 4.26% | +1.5% |
| Q1 2019 | $33,179,000 | +11.6% | 251,321 | -12.8% | 4.20% | -0.9% |
| Q4 2018 | $29,731,000 | -3.0% | 288,317 | +2.2% | 4.23% | +5.4% |
| Q3 2018 | $30,647,000 | +10.7% | 282,047 | +0.6% | 4.02% | -0.3% |
| Q2 2018 | $27,674,000 | -0.9% | 280,440 | -1.7% | 4.03% | -3.6% |
| Q1 2018 | $27,931,000 | +5.4% | 285,274 | -0.0% | 4.18% | +4.3% |
| Q4 2017 | $26,492,000 | +10.3% | 285,416 | +1.9% | 4.01% | +5.0% |
| Q3 2017 | $24,020,000 | +5.0% | 280,023 | +3.3% | 3.82% | +2.4% |
| Q2 2017 | $22,874,000 | +1.0% | 271,055 | +2.3% | 3.73% | -4.5% |
| Q1 2017 | $22,654,000 | +11.6% | 264,868 | +1.6% | 3.90% | +3.0% |
| Q4 2016 | $20,294,000 | +0.7% | 260,718 | +1.4% | 3.79% | +0.2% |
| Q3 2016 | $20,146,000 | -6.9% | 256,992 | +20.0% | 3.78% | -8.6% |
| Q2 2016 | $21,639,000 | +6.2% | 214,245 | -0.2% | 4.14% | +2.0% |
| Q1 2016 | $20,374,000 | +3.9% | 214,778 | +1.7% | 4.06% | -2.3% |
| Q4 2015 | $19,607,000 | +3.6% | 211,101 | -4.9% | 4.15% | -2.2% |
| Q3 2015 | $18,923,000 | -1.1% | 222,074 | -0.7% | 4.24% | +5.0% |
| Q2 2015 | $19,140,000 | +1.6% | 223,623 | +0.8% | 4.04% | +3.0% |
| Q1 2015 | $18,840,000 | +0.9% | 221,911 | +1.8% | 3.92% | -1.7% |
| Q4 2014 | $18,681,000 | +10.8% | 217,959 | -1.8% | 3.99% | +23.0% |
| Q3 2014 | $16,858,000 | -1.0% | 221,879 | +2.6% | 3.25% | -1.4% |
| Q2 2014 | $17,020,000 | +5.8% | 216,184 | +0.8% | 3.29% | +2.5% |
| Q1 2014 | $16,088,000 | -2.2% | 214,505 | +0.6% | 3.21% | -3.2% |
| Q4 2013 | $16,457,000 | +10.6% | 213,173 | -0.7% | 3.32% | -0.9% |
| Q3 2013 | $14,882,000 | +9.6% | 214,691 | +0.1% | 3.35% | +1.3% |
| Q2 2013 | $13,581,000 | – | 214,550 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |